Research Analysts Issue Forecasts for Organigram Q3 Earnings

Organigram Holdings Inc. (NASDAQ:OGI) – Equities researchers at Atb Cap Markets issued their Q3 2025 earnings per share (EPS) estimates for Organigram in a note issued to investors on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes forecasts that the company will post earnings of ($0.01) per share for the quarter. The consensus estimate for Organigram’s current full-year earnings is ($0.20) per share. Atb Cap Markets also issued estimates for Organigram’s Q4 2025 earnings at ($0.01) EPS.

Organigram Price Performance

Shares of NASDAQ OGI opened at $1.46 on Friday. The stock has a market cap of $184.19 million, a PE ratio of -3.48 and a beta of 1.02. Organigram has a 1 year low of $1.21 and a 1 year high of $2.91. The firm has a fifty day moving average price of $1.62 and a 200-day moving average price of $1.67.

Organigram (NASDAQ:OGI) last released its earnings results on Wednesday, December 18th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.01). Organigram had a negative return on equity of 16.76% and a negative net margin of 45.57%.

Hedge Funds Weigh In On Organigram

Hedge funds have recently made changes to their positions in the business. Renaissance Technologies LLC lifted its stake in Organigram by 40.8% in the 2nd quarter. Renaissance Technologies LLC now owns 816,948 shares of the company’s stock worth $1,258,000 after purchasing an additional 236,700 shares in the last quarter. Tidal Investments LLC raised its holdings in shares of Organigram by 8.3% during the 3rd quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock worth $3,526,000 after acquiring an additional 149,171 shares in the last quarter. AdvisorShares Investments LLC raised its position in shares of Organigram by 11.8% during the 2nd quarter. AdvisorShares Investments LLC now owns 1,000,126 shares of the company’s stock valued at $1,540,000 after buying an additional 105,468 shares in the last quarter. Finally, Toronto Dominion Bank lifted its position in Organigram by 803.7% in the third quarter. Toronto Dominion Bank now owns 16,727 shares of the company’s stock worth $30,000 after buying an additional 14,876 shares during the last quarter. Institutional investors own 34.63% of the company’s stock.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.